Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants [Phase 2]

View source ↗

Summary

Phase 2 pediatric study of cefiderocol in hospitalized children evaluating safety, tolerability, and pharmacokinetics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Hospital-acquired Bacterial Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Cefiderocol (Fetroja) (cefiderocol)

Snippet

Sponsor: Shionogi | Conditions: Gram-negative Bacterial Infections, Hospital Acquired Bacterial Pneumonia (HABP) | Phase 2 | Status: COMPLETED